Spironolactone.ppt

ashfaq22 4,718 views 10 slides Feb 14, 2023
Slide 1
Slide 1 of 10
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10

About This Presentation

Diuretics


Slide Content

Spironolactone
Presented By
Qasim Jan

Introduction
•Class:Diuretic
Potassium Sparing
Selective Aldosterone Blocker
•Strength:
25MG TAB
50MG TAB
100MG TAB
•Pregnancy Category: C

Pharmacokinetics
•Absorption: Rapidly absorbed from GIT after oral administration
•Protein Binding: 90% Plasma protein binding
•Metabolism: Hepatic & Testicular CYP450
•Excretion: Primarily in Urine, secondarily in Bile
•Half Life: 10 minutes

Indications
•Edema associated with:
•Congestive Heart Failure
•Excessive Aldosterone Excretion
•Hypertension
•Primary Hyperaldosteronism
•Hypokalemia
•Acne in Woman
•Hirsutism

Dosage
•Edema:
Oral:25-200 mg daily in 1-2 divided doses
•Hypokalemia:
Oral:25-100 mg once daily
•Hypertension :
Oral:25-50 mg daily in 1-2 divided doses

•Diagnosis of primary aldosteronism:
Oral:Long test: 400 mg once daily for 3-4 weeks;
short test:400 mg once daily for 4 days
•Heart Failure:
12.5-25 mg once daily; maximum daily dose:
50 mg. If 25 mg once daily not tolerated, may reduce to 25
mg every other day

•Acne in women (unlabeled use):
•Oral:50-200 mg once daily
•Hirsutism in women (unlabeled use):
•Oral:50-200 mg daily in 1-2 divided doses.

Common side effect:
•Cardiovascular: Vasculitis
•Central nervous system: Ataxia, confusion, drowsiness, headache,
lethargy
•Dermatologic:Erythematous maculopapular rash, Stevens-Johnson
syndrome, toxic epidermal necrolysis, urticaria
•Endocrine & metabolic: Amenorrhea, gynecomastia, hyperkalemia

•Gastrointestinal: Abdominal cramps, diarrhea, gastritis,
gastrointestinal hemorrhage, gastrointestinal ulcer, nausea, vomiting
•Genitourinary: Impotence, irregular menses, postmenopausal
bleeding
•Hematologic & oncologic: Agranulocytosis, malignant neoplasm of
breast
•Hepatic:Hepatotoxicity

Interactions
•The risk or severity of adverse effects can be increased when
Spironolactone is combined with Acebutolol.
•Aceclofenac may decrease the antihypertensive activities of
Spironolactone.
•The therapeutic efficacy of Spironolactone can be decreased when
used in combination with Acemetacin.
•The therapeutic efficacy of Acetyldigitoxincan be decreased when
used in combination with Spironolactone.
Tags